Author:
Koole Simone N,Huisman Atse H,Timmers Lonneke,Westgeest Hans M,van Breugel Edwin,Sonke Gabe S,van Waalwijk van Doorn-Khosrovani Sahar Barjesteh
Reference50 articles.
1. Human medicines: highlights of 2021,2022
2. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014–16: cross sectional analysis;Naci;BMJ,2019
3. European marketing authorizations granted based on a single pivotal clinical trial: the rule or the exception?;Morant;Clin Pharmacol Ther,2018
4. Weighing of evidence by health technology assessment bodies: retrospective study of reimbursement recommendations for conditionally approved drugs;Vreman;Clin Pharmacol Ther,2019
5. Precision medicines have faster approvals based on fewer and smaller trials than other medicines;Pregelj;Health Aff (Millwood),2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献